Ttims lrcc requirement
Ended Definitive Contract Awarded Last action
- Contract number
- 75F40121C00196
- Awardee
-
Vitalant UEI GKT4L2JZJ622
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $7,319,311
Award facts
- Opportunity
-
- Transfusion-Transmissible Infections Monitoring System (TTIMS) Laboratory & Risk Factor Database Coordinating Center (LRCC) Solicitation · FDARFP1238397 · Posted Aug 22, 2021
- Contract value 100% obligated
- $7,319,311.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541990 All Other Professional, Scientific, and Technical Services
- PSC
- B599 Special Studies/Analysis- Other
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Scottsdale, AZ 85257, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $1,618,321 | |
| Exercise an Option | $1,864,547 | |
| Change Order | $0 | |
| Exercise an Option | $1,974,713 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $1,861,730 |
About this award
This is a $7,319,311.00 firm-fixed-price federal contract awarded by the Food and Drug Administration (FDA) to Vitalant Research Institute (VRI), a non-profit organization, to serve as the Transfusion-Transmissible Infections Monitoring System (TTIMS) Laboratory and Risk Factor Database Coordinating Center (LRCC). The contract has a completion date of September 29, 2025. The LRCC will coordinate laboratory testing, data collection, and analysis to monitor transfusion-transmitted infections and associated risk factors in the U.S. blood donor population.
VRI has subcontracted with Oneblood, Inc., New York Blood Center, and Creative Testing Solutions, all non-profit organizations, to support the collection of donor data, biospecimen samples, and specialized testing. The contract does not have a set-aside designation. This award aligns with the FDA's mission to ensure the safety and availability of the U.S. blood supply through ongoing surveillance and research.
Subawards
| Subcontractor | Amount | Awarded |
|---|---|---|
| Creative Testing Solutions | $111,738 | |
| Oneblood, Inc. | $327,069 | |
| The American National Red Cross | $270,177 | |
| New York Blood Center, Inc. | $121,625 | |
| The American National Red Cross | $277,979 | |
| New York Blood Center, Inc. | $128,779 | |
| Creative Testing Solutions | $122,780 | |
| Oneblood, Inc. | $318,372 |
Quick answers
Who was awarded contract 75F40121C00196?
75F40121C00196 was awarded to Vitalant by Food and Drug Administration (Department of Health and Human Services) on September 27, 2021.
How much is contract 75F40121C00196 worth?
The government has obligated $7,319,311 on 75F40121C00196.
Was contract 75F40121C00196 competed?
The extent of competition for 75F40121C00196 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award